Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| 17,500 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | MEXER◷◆ | 16,182 | — | — | — | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | SSELL◷ | 300 | $85.53 | $25.7K | -100.0% | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | SSELL◷ | 200 | $83.38 | $16.7K | -40.0% | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | SSELL◷ | 3,865 | $82.66 | $319.5K | -88.5% | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | SSELL◷ | 23,465 | $81.75 | $1.9M | -84.3% | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | SSELL◷ | 15,852 | $80.71 | $1.3M | -36.3% | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | MEXER◷ | 10,000 | $21.77 | $217.7K | +29.7% | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | MEXER◷ | 17,500 | $22.07 | $386.2K | +108.1% | Open the original filing on SEC.gov |
| Mar 12 | DNTH | Dianthus Therapeutics,… | MEXER◷ | 16,182 | $17.88 | $289.3K | — | Open the original filing on SEC.gov |
| Feb 3 | DNTH | Dianthus Therapeutics,… | AGRANT◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |